Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aldoxorubicin Continues To Prove Itself As A Viable Cancer Treatment
Seeking Alpha
Tuesday, November 19, 2013 - 12:30pm
tags:
aldoxorubicin, cancer, chemotherapy, CytRx
Two Drugs, Designed To Help Patients, Actually Hurt Them
TheStreet.com
Tuesday, November 19, 2013 - 12:28pm
tags:
Vical, Anthera, varespladib, Allovectin-7
Keep an Eye on BioMarin, Amgen, Merck, and AstraZeneca Today
Motley Fool
Tuesday, November 19, 2013 - 12:24pm
tags:
Biomarin, Amgen, Merck, AstraZeneca
JLL Forms New Pharma Firm With DSM in $2.6 Billion Deal
Bloomberg
Tuesday, November 19, 2013 - 8:13am
tags:
Royal DSM, Patheon
Glaxo and Theravance Get European Marketing Approval for Relvar Ellipta
Motley Fool
Tuesday, November 19, 2013 - 8:11am
tags:
GSK, Europe, COPD, Theravance, Relvar Ellipta
Obamacare Failure May Shave 30% From U.S. Drug Sales
Bloomberg
Tuesday, November 19, 2013 - 8:09am
tags:
Affordable Care Act
Horizon obtains US rights to arthritis drug Vimovo
Yahoo/AP
Tuesday, November 19, 2013 - 7:59am
tags:
vivmo, Horizon Pharma, osteoarthritis, rheumatoid arthritis
Medtronic second-quarter earnings rise; top estimates
Reuters
Tuesday, November 19, 2013 - 7:57am
tags:
earnings, devices, Medtronic
3 Innovative Biotech Companies Poised To Shine At TAP Partnership Conference
Seeking Alpha
Tuesday, November 19, 2013 - 7:55am
tags:
Geron, Cellceutix, Brilacidin, Cytori
Why The FDA Got It Wrong And Why It Will Approve Vascepa For ANCHOR SNDA Submission
Seeking Alpha
Tuesday, November 19, 2013 - 7:42am
tags:
FDA, Amarin, Vascepa, ANCHOR
Biotech Meds Are Swelling Those Pharma Pipelines
Forbes
Tuesday, November 19, 2013 - 7:41am
tags:
biotech
Alzheimer's Disease Could Become the Next Frontier in Pharmaceutical Research
Motley Fool
Tuesday, November 19, 2013 - 7:40am
tags:
Alzheimer's disease, R&D, JNJ, Eli Lilly, Pfizer, Elan, General Electric, Vizamyl, Amyvid, bapineuzumab, solanezumab
J&J’s Janssen Loses $11 Million Jury Verdict Over Topamax
Bloomberg
Tuesday, November 19, 2013 - 7:38am
tags:
Janssen, JNJ, Topamax, birth defects
FDA approving drugs faster, and it may stay that way, report says
Marketwatch
Tuesday, November 19, 2013 - 7:37am
tags:
FDA, drug approvals
Gilead's HIV-1 Drug Wins Approval in Europe
Motley Fool
Tuesday, November 19, 2013 - 7:37am
tags:
HIV-1, Gilead Sciences, Vitekta, Europe
Don't Crown the Hepatitis C Drug Winner Just Yet
Motley Fool
Tuesday, November 19, 2013 - 7:35am
tags:
hepatitis C, Gilead Sciences, ABT-333, Ribavirin, ABT-450, ritonavir, ABT-267, AbbVie
Aegerion reports results from Phase 3 study of Juxtapid
Yahoo/Fly on the Wall
Tuesday, November 19, 2013 - 7:27am
tags:
Aegerion, Juxtapid, Homozygous Familial Hypercholesterolemia
Celgene's Revlimid Faces a Tough Sell
Motley Fool
Tuesday, November 19, 2013 - 7:25am
tags:
Celgene, Revlimid, JNJ, Multiple Myeloma
Biogen Idec 5-Year Revenue Outlook
Seeking Alpha
Tuesday, November 19, 2013 - 7:24am
tags:
Biogen Idec
US Senate Passes Compounding And Track-And-Trace Bill
Pharmalot
Monday, November 18, 2013 - 5:08pm
tags:
compounding pharmacies, track and trace bill

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.